Malini Chatterjee, MS, PhD, is a Managing Director @ Blueprint Lifescience Group.
Since 2013 Malini heads up East Coast operations of Blueprint Lifescience Group. She joined Blueprint after a 10-year period of investing as analyst and eventually portfolio manager for biotech, specialty pharma and pharma stocks at institutional funds such as CR Intrinsic Investors/SAC Capital, Alexandra Investments. Prior to Malini’s foray into Wall Street, she worked as a senior consultant for Genentech Bio Oncology in the medical and scientific communications team working towards the Phase III clinical trials and launch of Avastin in the U.S. . Malini also brings to Blueprint independent consultancy experience having launched Bio Intuition LLC, a provider of topic specific “deep-dive” analyses to both large institutional investors and small biotech companies. Malini has a Ph.D. in molecular oncology from Columbia University and an M.S. with a double major in Math and Microbiology from the University of Bombay, India.